Skip to content

Acute Diverticulitis and Advanced Colonic Neoplasia. When to Perform Colonoscopy (ADACOLON Study)

Clinical Trial for the Determination of Advanced Colonic Neoplasia Prevalence and the Need for Colonoscopy in Complicated and Uncomplicated Acute Diverticulitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03557216
Acronym
ADACOLON
Enrollment
313
Registered
2018-06-14
Start date
2018-06-15
Completion date
2022-08-23
Last updated
2022-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Neoplasms, Diverticulitis, Colonic

Keywords

Diverticulitis, Advanced colonic neoplasm, Colonoscopy

Brief summary

This study evaluate the prevalence of advanced colonic neoplasia (ACN) in acute diverticulitis. A sub-analysis of complicated and uncomplicated acute diverticulitis will be made in order to determinate whether there are differences of advanced colonic neoplasia (ANC) prevalence in both groups and to assess if a colonoscopy is necessary.

Detailed description

This is a prospective study that eliminates biases in the selection, design and variability of retrospective studies to reliably assess the global prevalence of advanced colon neoplasia (ACN) and the difference in prevalence among populations with complicated and uncomplicated acute diverticulitis diagnosed by computed tomography. Another objective is to assess the diagnostic prediction of computed tomography to detect ACN in acute diverticulitis. It also aims to assess the safety and quality of colonoscopy in a patient recently diagnosed with acute diverticulitis. Finally, it aims to study whether other diagnostic tools such as the presence of clinical risk symptoms or the performance of fecal biological tests could help in narrowing the indication of colonoscopy in this clinical scenario.

Interventions

DIAGNOSTIC_TESTColonoscopy

Anal introduction of a long, flexible, tubular instrument about 1/2-inch in diameter that transmits an image of the lining of the colon so the doctor can examine it for any abnormalities

DIAGNOSTIC_TESTFecal immunochemical and occult blood test

A test for fecal occult blood looks for blood in your feces. It can be a sign of a problem in the digestive system, such as a polyp or cancer in the colon.

Calprotectin is a protein released by neutrophils. When there is inflammation in the colon, neutrophils move to the area and release calprotectin, resulting in an increased level in the stool. This test measures the level of calprotectin in stool as a way to detect inflammation and lesions in the colon.

Sponsors

Parc de Salut Mar
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Diagnostic clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

All patients consecutively diagnosed with acute diverticulitis in the participating hospitals during the study inclusion period will be included. For this purpose, a multidetector computerized tomography confirming the diagnosis of acute diverticulitis must be performed on all patients with initial clinical suspicion.

Exclusion criteria

1. Patient refusal to participate in the study. 2. Impossibility of obtaining informed consent by the patient or guardian. 3. Age \<18 years and\> 85 years 4. Impossibility of performing a diagnostic CT of AD. 5. Intercurrent medical or surgical process with prolonged recovery in time that prevents a colonoscopy before 6 months after the resolution of the episode of acute diverticulitis.

Design outcomes

Primary

MeasureTime frameDescription
Presence of ACNAt the moment of colonoscopy.For our study, ANC is all colonic lesions that are advanced adenoma or colorectal cancer. Advanced adenoma is defined as that adenoma with size\> 10mm, villous component in\> 25% and / or high-grade dysplasia or all serrated lesions\> 10mm with or without dysplasia. Colonoscopy is the gold standard for ANC detection.

Secondary

MeasureTime frameDescription
Clinical symptoms predictive value for ANC detectionAt the moment of colonoscopy.Assessment of diagnostic prediction of clinical symptoms to detect ANC in acute diverticulitis.
Colonoscopy qualityAt the moment of colonoscopy.A quality colonoscopy will be considered as a complete colonoscopy, with an adequate preparation according to the Boston scale (score greater than or equal to 2 in all segments) and with resection of all polyps \<20mm detected.
CT predictive value for ACN detectionAt the moment of colonoscopy.Assessment of diagnostic prediction of computed tomography to detect ANC in acute diverticulitis.
FIT predictive value for ANC detectionAt the moment of colonoscopy.Assessment of diagnostic prediction of FIT to detect ANC in acute diverticulitis.
Fecal calprotectin test predictive value for ANC detectionAt the moment of colonoscopy.Assessment of diagnostic prediction of fecal calprotectin test to detect ANC in acute diverticulitis.
Colonoscopy security30 days post-colonoscopy.Assessment of complications arising from colonoscopy. Mayor complication of colonoscopy is defined as the presence of perforation, hemorrhage, postpolypectomy syndrome, thromboembolic accident, acute myocardial infarction and / or death, and minor complication of colonoscopy for the rest of the events.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026